Insulin Dosage Optimization Based on Model Predictive Control with the Model Parameters Estimation

Abstract:

Diabetes is a disease characterized by the inability of the pancreas to regulate blood glucose concentration. The development of the closed-loop control method for the treatment of type 1 diabetes is a highly desired endeavor for patients, physicians and scientists. Focusing on the need for maintaining normal glycaemia, the paper proposes an integrated closed-loop control method, which is the model predictive control (MPC) method combined with model parameters estimation. Using the static glucose model to be the internal model can’t achieve the good performance in different objects because of the individual differences. By updating the internal controller model with current measurement information using the parameters estimation, mismatch between the actual controlled object and the internal controller model is significantly reduced. Therefore, the predictions of future glucose values using the updated model are more accurate than those of the static input–output model. Finally, the integrated control method was tested on the T1DM simulator which was accepted by the FDA. Four objects are selected randomly in T1DM simulator. The control results showed it can modulate the glucose concentration to 85~120 mg/dl without severe hypoglycemia in the effective time. In conclusion, it is promising for the control of glucose concentration in subjects with type 1 diabetes.

• Periodical: Advanced Materials Research (Volumes 971-973)
• Pages: 1222-1229
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.971-973.1222
• Online since: June 2014
• Authors: Sha Sha Zhang, Ming Zhong*, Ya Xin Liu
• Keywords: Glucose Regulation, Model Parameters Estimation, Model Predictive Control, Simulation Validation

References

[1] O.H. Franco, E.W. Steyerberg, F.B. Hu, J. Mackenbach, W. Nusselder. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch. Intern. Med. 167 (11) (2007) 1145–1151.

DOI: 10.1001/archinte.167.11.1145

[2] Diabetes Control and Complications Trials Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 77–986.

DOI: 10.1056/nejm199309303291401

[3] Baoyi Li, Yun Xie, Jia Liu. Bergman min-model method and the research orientation. Foreign medical endocrinology study booklet, November 25 (6), 2005: 422-429.

[4] G M STEIL, BUD CLARK, SAMI KANDERIAN, and K REBRIN. Modeling Insulin Action for Development of a Closed-Loop Artificial Pancreas [J]. DIABETES TECHNOLOGY & THERAPEUTICS, Volume 7, Number 1, (2005).

DOI: 10.1089/dia.2005.7.94

[5] Roman Hovorka, Ludovic J Chassin, Martin Ellmerer, Johannes Plank and Malgorzata EWilinska. A simulation model of glucose regulation in the critically ill. IOP publishing, Physiol. Meas. 29 (2008) 959–978.

DOI: 10.1088/0967-3334/29/8/008

[6] Y. Ramprasad, G. P. Rangaiah, and S. Lakshminarayanan. Robust PID Controller for Blood Glucose Regulation in Type I Diabetics. Ind. Eng. Chem. Res. 2004, 43, 8257-8268.

DOI: 10.1021/ie049546a

[7] Sh. Yasini, M. B. Naghibi-Sistani, A. Karimpour. Active Insulin Infusion Using Fuzzy-Based Closed-loop Control. Proceedings of 2008 3rd International Conference on Intelligent System and Knowledge Engineering.

DOI: 10.1109/iske.2008.4730968

[8] H.K. Phee, W.L. Tung, C. Quek. A personalized approach to insulin regulation using brain-inspired neural semantic memory in diabetic glucose control. 1-4244-1340-0/07/$25. 00_c 2007 IEEE.

DOI: 10.1109/cec.2007.4424804

[9] Youqing Wang, Member, Eyal Dassau, Member, and Francis J. Doyle, Fellow. Closed-Loop Control of Artificial Pancreatic β-Cell in Type 1 Diabetes Mellitus Using Model Predictive Iterative Learning Control. IEEE transactions on biomedical engineering, VOL. 57, NO. 2, FEBRUARY (2010).

DOI: 10.1109/tbme.2009.2024409

[10] L. Magni a, D.M. Raimondo a, C. Dalla Manb, G. De Nicolao a, B. Kovatchev c, C. Cobelli. Model predictive control of glucose concentration in type I diabetic patients: An in silico trial. Biomedical Signal Processing and Control 4 (2009) 338–346.

DOI: 10.1016/j.bspc.2009.04.003

[11] R. Zurakowski and A. R. Teel. A model predictive control based scheduling method for HIV therapy, J. Theoretical Biology, vol. 238, p.368–382, (2006).

DOI: 10.1016/j.jtbi.2005.05.004

[12] Benyamin Grosman, Ph.D., Eyal Dassau, Ph.D., Howard C. Zisser, M.D., Lois Jovanovic, M.D., and Francis J. Doyle, Ph.D. Zone Model Predictive Control: A Strategy to Minimize Hyper-and Hypoglycemic Events. Journal of Diabetes Science and Technology Volume 4, Issue 4, July (2010).

DOI: 10.1177/193229681000400428

[13] Malgorzata E. Wilinska, Ph.D., Ludovic J. Chassin, Ph.D., Carlo L. Acerini, M.D., Janet M. Allen, R.N., David B. Dunger, M.D., and Roman Hovorka, Ph.D. Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes. Journal of Diabetes Science and Technology Volume 4, Issue 1, January (2010).

DOI: 10.1177/193229681000400117

[14] G.M. STEIL, Ph.D., BUD CLARK, M.A., SAMI KANDERIAN, M.S.E., and K. REBRIN, M.D., Ph.D. Modeling Insulin Action for Development of a Closed-Loop Artificial Pancreas. DIABETES TECHNOLOGY & THERAPEUTICS Volume 7, Number 1, (2005).

DOI: 10.1089/dia.2005.7.94

[15] Claudio Cobelli, Chiara Dalla Man, Giovanni Sparacino, Lalo Magni, Giuseppe De Nicolao, andBoris P. Kovatchev. Diabetes: Models, Signals, and Control. IEEE REVIEWS IN BIOMEDICAL ENGINEERING, VOL. 2, (2009).

DOI: 10.1109/rbme.2009.2036073

[16] Richard N. Bergman, Garry M. Steil, David C. Bradley, and Richard M. Watanabe. MODELING OF INSULIN ACTION IN VIVO. Annu. Rev. Physiol. 1992. 54: 861-83.

DOI: 10.1146/annurev.ph.54.030192.004241